Difference between revisions of "Part:BBa K2913005"
Line 3: | Line 3: | ||
<partinfo>BBa_K2913005 short</partinfo> | <partinfo>BBa_K2913005 short</partinfo> | ||
− | This composite part consists of Pluc BBa_K2913003, conjugation sequence BBa_K2913002, and a random sequence as long as HucO sequence. Phuc1 includes one hucR binding site inside the Pluc. In the absence of uric acid (or xanthine), HucR protein binds to Pluc and prevents the binding of RNA polymerase. When uric acid (or xanthine) antagonizes the HucR-Pluc binding, RNA polymerase initiates a transcriptional process of downstream genes. | + | This composite part consists of Pluc [https://parts.igem.org/Part:BBa_K2913003 BBa_K2913003], conjugation sequence [https://parts.igem.org/Part:BBa_K2913002 BBa_K2913002], and a random sequence as long as HucO sequence. Phuc1 includes one hucR binding site inside the [https://parts.igem.org/Part:BBa_K2913003 Pluc]. In the absence of uric acid (or xanthine), HucR protein binds to Pluc and prevents the binding of RNA polymerase. When uric acid (or xanthine) antagonizes the HucR-Pluc binding, RNA polymerase initiates a transcriptional process of downstream genes. |
Line 11: | Line 11: | ||
=result= | =result= | ||
− | The promoter should be fully activated at the highest uric acid concentration safe to human body (0.465mM). The activity of the promoters were determined by measuring the fluorescence intensity of the enhanced green fluorescent protein (EGFP). The results showed that the Phuc2 had the highest sensitive and activity at the conditions of 0.1mM and 0.01 mM of uric acid. Then, the EGFP coding sequence was replaced by the uricase gene to check whether the module could sense and metabolize the uric acid. As shown in Fig.5, the control group kept constant uric acid levels, but the experimental group displayed reduced uric acid concentrations in a time-dependent manner in the first 3 h of incubation. After that, the uric acid levels kept constant. The data suggested that the expression of uricase was induced at high concentrations of uric acid and repressed at its relatively low concentrations. The result indicated that the expression of uricase was under the control of Phuc2 responsive to the concentration of uric acid. | + | The promoter should be fully activated at the highest uric acid concentration safe to human body (0.465mM). The activity of the promoters were determined by measuring the fluorescence intensity of the enhanced green fluorescent protein (EGFP). The results showed that the Phuc2 had the highest sensitive and activity at the conditions of 0.1mM and 0.01 mM of uric acid. Then, the EGFP coding sequence was replaced by the uricase gene to check whether the module could sense and metabolize the uric acid. As shown in Fig.5, the control group kept constant uric acid levels, but the experimental group displayed reduced uric acid concentrations in a time-dependent manner in the first 3 h of incubation. After that, the uric acid levels kept constant. The data suggested that the expression of uricase was induced at high concentrations of uric acid and repressed at its relatively low concentrations. The result indicated that the expression of uricase was under the control of Phuc2 responsive to the concentration of uric acid.<b>[https://2019.igem.org/Team:NEFU_China/Results See more information on iGEM19_NEFU_China's Result PAGE]</b> |
[[File:T--NEFU_China--parts--hucr3.png|500px|thumb|left|Fig. 3 Comparison of induction strength of the promoter Phuc1 (circle), Phuc2 (square), and Phuc3 (triangle) by measuring green fluorescence of EGFP at 0.1 mM of the inducer uric acid (with 1:100 dilution of culture inoculation). Error bars represent standard deviations.]] | [[File:T--NEFU_China--parts--hucr3.png|500px|thumb|left|Fig. 3 Comparison of induction strength of the promoter Phuc1 (circle), Phuc2 (square), and Phuc3 (triangle) by measuring green fluorescence of EGFP at 0.1 mM of the inducer uric acid (with 1:100 dilution of culture inoculation). Error bars represent standard deviations.]] |
Revision as of 20:36, 21 October 2019
Phuc1, one of the series of Phuc
This composite part consists of Pluc BBa_K2913003, conjugation sequence BBa_K2913002, and a random sequence as long as HucO sequence. Phuc1 includes one hucR binding site inside the Pluc. In the absence of uric acid (or xanthine), HucR protein binds to Pluc and prevents the binding of RNA polymerase. When uric acid (or xanthine) antagonizes the HucR-Pluc binding, RNA polymerase initiates a transcriptional process of downstream genes.
Usage and Biology
result
The promoter should be fully activated at the highest uric acid concentration safe to human body (0.465mM). The activity of the promoters were determined by measuring the fluorescence intensity of the enhanced green fluorescent protein (EGFP). The results showed that the Phuc2 had the highest sensitive and activity at the conditions of 0.1mM and 0.01 mM of uric acid. Then, the EGFP coding sequence was replaced by the uricase gene to check whether the module could sense and metabolize the uric acid. As shown in Fig.5, the control group kept constant uric acid levels, but the experimental group displayed reduced uric acid concentrations in a time-dependent manner in the first 3 h of incubation. After that, the uric acid levels kept constant. The data suggested that the expression of uricase was induced at high concentrations of uric acid and repressed at its relatively low concentrations. The result indicated that the expression of uricase was under the control of Phuc2 responsive to the concentration of uric acid.See more information on iGEM19_NEFU_China's Result PAGE
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]